| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1749-6632.2009.05160.X |
| P698 | PubMed publication ID | 20074271 |
| P50 | author | Jodi K. Maranchie | Q38155493 |
| Leonard Appleman | Q46857188 | ||
| William J Buchser | Q51659023 | ||
| Michael T Lotze | Q89121415 | ||
| Herbert J. Zeh, III | Q92244196 | ||
| P2093 | author name string | Xiaoyan Liang | |
| Per H Basse | |||
| Michael E de Vera | |||
| Antonio Romo de Vivar Chavez | |||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | interleukins | Q194908 |
| P304 | page(s) | 14-27 | |
| P577 | publication date | 2009-12-01 | |
| P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
| P1476 | title | Pharmacologic administration of interleukin-2 | |
| P478 | volume | 1182 |
| Q92965479 | A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control |
| Q56969482 | An Overview of Cytokines and Cytokine Antagonists as Therapeutic Agents |
| Q36585665 | Autophagy is required for IL-2-mediated fibroblast growth |
| Q39364287 | Cell-mediated autophagy promotes cancer cell survival. |
| Q33811204 | Challenges and developing solutions for increasing the benefits of IL-2 treatment in tumor therapy |
| Q37862817 | Cytokines and pain. |
| Q39077338 | Effect of combined treatment with recombinant interleukin-2 and allicin on pancreatic cancer |
| Q41963722 | Meeting report: The 13th Annual Meeting of the Translational Research Cancer Centers Consortium (TrC3); Immune Suppression and the Tumor Microenvironment, Columbus, Ohio; March 1-2, 2010. |
| Q55100965 | Prospects of IL-2 in Cancer Immunotherapy. |
| Q37847059 | Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases |
| Q47131174 | Regulatory T cells control toxicity in a humanized model of IL-2 therapy |
| Q34055865 | Selective expansion of chimeric antigen receptor-targeted T-cells with potent effector function using interleukin-4. |
| Q90382339 | Targeting tumor cells with antibodies enhances anti-tumor immunity |
Search more.